FolioMetrix’s Edwards Lifesciences EW Stock Holding History

FolioMetrix’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1M	Buy	47,400 +11,400	+32%	+$257K	0.42%	45
2015 Q1	$855K	Buy	36,000 +18,600	+107%	+$417K	0.43%	53
2014 Q4	$359K	Buy	+17,400	New	+$350K	0.25%	86

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

FolioMetrix's EW Position: Q2 2015 in Review

FolioMetrix increased its Edwards Lifesciences (EW) stake by 32% in Q2 2015, buying an estimated $257K and bringing the position to 47,400 shares worth $1M. The position accounts for 0.42% of the portfolio, ranked #45.

FolioMetrix first reported a position in EW in Q4 2014 and has held it in 3 quarters since. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

FolioMetrix held 47,400 shares of Edwards Lifesciences worth $1M as of Q2 2015.
FolioMetrix bought 11,400 Edwards Lifesciences shares in Q2 2015, an estimated $257K.
Edwards Lifesciences made up 0.42% of FolioMetrix's portfolio in Q2 2015, its #45 holding.
FolioMetrix first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 3 quarters since.
579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.